137 related articles for article (PubMed ID: 12009627)
1. Cyclosporine A-related hemolytic uremic syndrome after living renal transplantation-case report.
Wołyniec W; Debska-Slizień A; Chamienia A; Ignacy Pirski M; Łysiak-Szydłowska W; Sledziński Z; Rutkowski B
Transplant Proc; 2002 Mar; 34(2):569-71. PubMed ID: 12009627
[No Abstract] [Full Text] [Related]
2. Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.
Bren AF; Kandus A; Buturovic J; Koselj M; Kaplan Pavlovcic S; Ponikvar R; Kovac D; Lindic J; Vizjak A; Ferluga D
Transplant Proc; 1998 Jun; 30(4):1201-3. PubMed ID: 9636487
[No Abstract] [Full Text] [Related]
3. A case of early onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Kim W; La BJ; Lee S; Yu HC; Cho BH; Kang MJ; Park SK
Clin Nephrol; 2003 Feb; 59(2):148-50. PubMed ID: 12608560
[No Abstract] [Full Text] [Related]
4. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
Wen YK; Chen ML
Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic and uremic syndrome after heart transplantation.
Mercadal L; Petitclerc T; Assogba U; Beaufils H; Deray G
Am J Nephrol; 2000; 20(5):418-20. PubMed ID: 11093002
[TBL] [Abstract][Full Text] [Related]
6. FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient.
Abdalla AH; al-Sulaiman MH; al-Khader AA
Transpl Int; 1994 Aug; 7(5):382-4. PubMed ID: 7527640
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
Said T; al-Mousawi M; Samhan M; Lao M
Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
[No Abstract] [Full Text] [Related]
8. Cyclosporine-induced hemolytic uremic syndrome: factors that obscure its diagnosis.
Katznelson S; Wilkinson A; Rosenthal TR; Cohen A; Nast C; Danovitch GM
Transplant Proc; 1994 Oct; 26(5):2608-9. PubMed ID: 7940812
[No Abstract] [Full Text] [Related]
9. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
10. Renovascular elements of the cyclosporine injury.
Curtis JJ
Transplant Proc; 1996 Aug; 28(4):2094-6. PubMed ID: 8769164
[No Abstract] [Full Text] [Related]
11. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
[TBL] [Abstract][Full Text] [Related]
12. Nonrecurrent hemolytic uremic syndrome (HUS de novo) as cause of acute renal failure after renal transplant.
Mazzali M; Dias EP; Ribeiro-Alves MA; Homsi E; Alves-Filho G
Ren Fail; 1997 Mar; 19(2):271-7. PubMed ID: 9101603
[No Abstract] [Full Text] [Related]
13. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation.
Lapointe M; Baillie GM; Bhaskar SS; Richardson MS; Self SE; Baliga PK; Rajagopalan PR
Clin Transplant; 1999 Dec; 13(6):526-30. PubMed ID: 10617244
[TBL] [Abstract][Full Text] [Related]
14. Outcome and prognosis of cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histopathologic study of 13 cases.
Bren AF; Kandus A; Koselj M; Buturovic J; Lindic J; Kovac D; Ponikvar R; Vizjak A; Ferluga D
Transplant Proc; 2002 Nov; 34(7):3005-6. PubMed ID: 12431685
[No Abstract] [Full Text] [Related]
15. De novo hemolytic uremia syndrome: a rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine.
Lucca LJ; Ressurreiçao FA; Ferraz AS; Costa RS; Costa JA; Pisi TM; Alves MR
Transplant Proc; 1992 Dec; 24(6):3098-9. PubMed ID: 1466073
[No Abstract] [Full Text] [Related]
16. Contribution of mycophenolate mofetil after withdrawal of cyclosporine to toxicity in kidney transplantation.
Hazzan M; Bourdon F; Dracon M; Lelièvre G; Noël C
Transplant Proc; 1998 Sep; 30(6):2809-10. PubMed ID: 9745575
[No Abstract] [Full Text] [Related]
17. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine-triggered hemolytic-uremic syndrome in kidney graft recipients: a series of 12 cases.
Bren AF; Kandus A; Lindic J; Kovac D; Buturović J; Vizjak A; Ferluga D
Transplant Proc; 2001; 33(7-8):3691-2. PubMed ID: 11750572
[No Abstract] [Full Text] [Related]
19. The reproducibility of cyclosporin-induced hemolytic uremic syndrome in a renal allograft recipient.
Ok E; Kursat S; Tokat Y; Cirit M; Tombuloglu M; Akcicek F
Nephron; 1996; 74(1):238. PubMed ID: 8883059
[No Abstract] [Full Text] [Related]
20. Uneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome.
Guella A; Daoud M; Al Dayel A
Nephrol Dial Transplant; 1998 Jul; 13(7):1864-5. PubMed ID: 9681750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
